Meet The Company Bridging Synthetic Biology Innovation With The World Of Insurance To Ensure Safe Food Production

  • 📰 Forbes
  • ⏱ Reading Time:
  • 57 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 53%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Terrible insurance policies often prevent innovative new ideas from penetrating the food and beverage industry. Aanika Biosciences has married the worlds of synbio and insurance to provide companies security to innovate freely.

... [+]Usually, crops from up to a hundred different farms are combined, packaged, and distributed. So, when an outbreak occurs, it can take months to confirm the originating farm. If, however, a crop is treated with a spore tag, it can be quickly exonerated if a simple qPCR test of contaminated product fails to identify the tag.

Not only can Aanika offer premiums up to 30% cheaper than what’s currently available, but their payouts will occur within 48 hours of an FDA notification of a problem. Determining whether a crop treated with Aanika’s spores is at the root of an outbreak is quick and easy: either a simple qPCR assay or an on-site isothermal test developed by Aanika that delivers results in just 10 minutes. This alone saves producers about 30-40% of the claim just by cutting down investigation time and costs.

“If we see that there's an edge biologically, we can look at that edge, really understand it, develop our own technology around it, and then structure an insurance product around it,” explains Bhuyan. “I think there’s a future where Aanika will insure companies using cutting edge technology because we understand what people are doing.

“ChatGPT is cool not just because it uses AI, but because it’s so mainstream now that even my mom is talking about it. I can see that happening with synthetic biology. If we can build a really successful company that happens to use synthetic biology, that would be a major win.”

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 394. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Primary-care company ChenMed to be led by UnitedHealthcare veteranChenMed just tapped a UnitedHealthcare veteran to take over as the clinic company confronts financial pressures
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »

Top AI Companies to Meet With Biden, Commit to Third-Party Testing and WatermarkingSeven leading AI firms including OpenAI, Microsoft, and Google have voluntarily committed to a series of frameworks intended to reduce AI risk.
ソース: Gizmodo - 🏆 556. / 51 続きを読む »

Medtech company NeurAxis upsizes IPO and lowers price to $6 a share vs. $8 previouslyNeurAxis, a medical technology company with an FDA-approved therapy to treat abdominal pain associated with IBS in adolescents aged 11 to 18 years old,...
ソース: MarketWatch - 🏆 3. / 97 続きを読む »